Polypeptide point modifications with fatty acid and amphiphilic block copolymers for enhanced brain delivery

被引:74
作者
Batrakova, EV
Vinogradov, SV
Robinson, SM
Niehoff, ML
Banks, WA
Kabanov, AV
机构
[1] Univ Nebraska, Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68198 USA
[2] Univ Nebraska, Med Ctr, Ctr Drug Delivery & Nanomed, Coll Pharm, Omaha, NE 68198 USA
[3] St Louis Univ, Sch Med, Dept Internal Med, Div Geriatr, St Louis, MO 63104 USA
[4] GRECC Vet Affairs Med Ctr ST Louis, St Louis, MO 63104 USA
关键词
D O I
10.1021/bc049730c
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
There is a tremendous need to enhance delivery of therapeutic polypeptides to the brain to treat disorders of the central nervous system (CNS). The brain delivery of many polypeptides is severely restricted by the blood-brain barrier (BBB). The present study demonstrates that point modifications of a BBB-impermeable polypeptide, horseradish peroxidase (HRP), with lipophilic (stearoyl) or amphiphilic (Pluronic block copolymer) moieties considerably enhance the transport of this polypeptide across the BBB and accumulation of the polypeptide in the brain in vitro and in vivo. The enzymatic activity of the HRP was preserved after the transport. The modifications of the HRP with amphiphilic block copolymer moieties through degradable disulfide links resulted in the most effective transport of the HRP across in vitro brain microvessel endothelial cell monolayers and efficient delivery of HRP to the brain. Stearoyl modification of HRP improved its penetration by about 60% but also increased the clearance from blood. Pluronic modification using increased penetration of the BBB and had no significant effect on clearance so that uptake by brain was almost doubled. These results show that point modification can improve delivery of even highly impermeable polypeptides to the brain.
引用
收藏
页码:793 / 802
页数:10
相关论文
共 28 条
  • [1] Banks J. E., 1999, Agricultural and Forest Entomology, V1, P165, DOI 10.1046/j.1461-9563.1999.00022.x
  • [2] Impaired transport of leptin across the blood-brain barrier in obesity is acquired and reversible
    Banks, WA
    Farrell, CL
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 285 (01): : E10 - E15
  • [3] Differential transport of a secretin analog across the blood-brain and blood-cerebrospinal fluid barriers of the mouse
    Banks, WA
    Goulet, M
    Rusche, JR
    Niehoff, ML
    Boismenu, R
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 302 (03) : 1062 - 1069
  • [4] Strategies for the delivery of leptin to the CNS
    Banks, WA
    Lebel, CP
    [J]. JOURNAL OF DRUG TARGETING, 2002, 10 (04) : 297 - 308
  • [5] Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells
    Batrakova, EV
    Li, S
    Alakhov, VY
    Miller, DW
    Kabanov, AV
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 304 (02) : 845 - 854
  • [6] Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers
    Batrakova, EV
    Li, S
    Miller, DW
    Kabanov, AV
    [J]. PHARMACEUTICAL RESEARCH, 1999, 16 (09) : 1366 - 1372
  • [7] TRANSPORT OF ALPHA-AMINOISOBUTYRIC-ACID ACROSS BRAIN CAPILLARY AND CELLULAR MEMBRANES
    BLASBERG, RG
    FENSTERMACHER, JD
    PATLAK, CS
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1983, 3 (01) : 8 - 32
  • [8] Brinton RD, 1999, INT J FERTIL WOMEN M, V44, P174
  • [9] FATTY-ACID ACYLATED FAB-FRAGMENTS OF ANTIBODIES TO NEUROSPECIFIC PROTEINS AS CARRIERS FOR NEUROLEPTIC TARGETED DELIVERY IN BRAIN
    CHEKHONIN, VP
    KABANOV, AV
    ZHIRKOV, YA
    MOROZOV, GV
    [J]. FEBS LETTERS, 1991, 287 (1-2) : 149 - 152
  • [10] Chekhonin VP, 1995, NEUROREPORT, V7, P129, DOI 10.1097/00001756-199512290-00031